Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats - PubMed (original) (raw)
Comparative Study
Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats
Masahiro Tanaka et al. Bone. 2004 Jun.
Abstract
Prostaglandin E(2) (PGE(2)) is essential for fracture healing. Systemic administration of EP4 ligands such as PGE(2) and other synthetic EP4 agonists appears to transduce anabolic signals by binding to receptor EP4. Therefore, the present study was designed to test whether administration of EP4 agonist accelerates the healing of drill-hole injury in the femoral diaphysis. After surgery, a total of 128 Wistar rats, at the age of 12 weeks, were assigned to basal control (n = 8), and three groups with respective doses of 0 (vehicle control), 10 (low-dose), and 30 (high-dose) microg/kg body weight of the agent were subcutaneously injected twice a day. Femoral specimens were obtained at 0, 5, 7, 14, 21, and 28 days. In EP4 agonist-treated groups, the total bone volume of the regenerating bone in the defect did not significantly differ, but the regenerated cortical bone volume measured by histomorphometry and cortical bone mineral content (Ct. BMC) by pQCT dose-dependently increased at 14 and 21 days compared to the control. In the high-dose group, the value of osteoclast surface significantly increased compared with that in the control at 14 days. Expression levels of osteocalcin and TRAP mRNAs in the injured tissue increased at 14 days. Expression levels of EP4, BMP-2, and RANKL mRNAs increased at 7 days in the high-dose group. The bone mineral values of the lumbar bone at 28 days, measured by DXA, did not differ in the three groups. These data indicated that systemic administration of EP4 agonist ONO-4819.CD accelerated cortical bone healing after drill-hole injury by upregulating the local turnover of the regenerating bone.
Similar articles
- Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading.
Hagino H, Kuraoka M, Kameyama Y, Okano T, Teshima R. Hagino H, et al. Bone. 2005 Mar;36(3):444-53. doi: 10.1016/j.bone.2004.12.013. Bone. 2005. PMID: 15777678 - Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur.
Nagashima M, Sakai A, Uchida S, Tanaka S, Tanaka M, Nakamura T. Nagashima M, et al. Bone. 2005 Mar;36(3):502-11. doi: 10.1016/j.bone.2004.11.013. Bone. 2005. PMID: 15777685 - Prostaglandin E2 EP4 receptor-selective agonist facilitates sternal healing after harvesting bilateral internal thoracic arteries in diabetic rats.
Marui A, Hirose K, Maruyama T, Arai Y, Huang Y, Doi K, Ikeda T, Komeda M. Marui A, et al. J Thorac Cardiovasc Surg. 2006 Mar;131(3):587-93. doi: 10.1016/j.jtcvs.2005.10.026. J Thorac Cardiovasc Surg. 2006. PMID: 16515909 - Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
Namikawa T, Terai H, Hoshino M, Kato M, Toyoda H, Yano K, Nakamura H, Takaoka K. Namikawa T, et al. Spine (Phila Pa 1976). 2007 Oct 1;32(21):2294-9. doi: 10.1097/BRS.0b013e318154c5b6. Spine (Phila Pa 1976). 2007. PMID: 17906568 - [Role of prostaglandin E2 in bone].
Oida H, Oda K, Maruyama T. Oida H, et al. Nihon Rinsho. 2004 Feb;62 Suppl 2:120-4. Nihon Rinsho. 2004. PMID: 15035109 Review. Japanese. No abstract available.
Cited by
- Design, Synthesis, Pharmacokinetics, and Biodistribution of a Series of Bone-Targeting EP4 Receptor Agonist Prodrugs for Treatment of Osteoporosis and Other Bone Conditions.
Thévenin M, Chen G, Kantham S, Sun C, Glogauer M, Young RN. Thévenin M, et al. ACS Pharmacol Transl Sci. 2021 Mar 10;4(2):908-925. doi: 10.1021/acsptsci.1c00027. eCollection 2021 Apr 9. ACS Pharmacol Transl Sci. 2021. PMID: 33860210 Free PMC article. - Fracture healing and lipid mediators.
O'Connor JP, Manigrasso MB, Kim BD, Subramanian S. O'Connor JP, et al. Bonekey Rep. 2014 Apr 2;3:517. doi: 10.1038/bonekey.2014.12. eCollection 2014. Bonekey Rep. 2014. PMID: 24795811 Free PMC article. Review. - Accelerated fracture healing in mice lacking the 5-lipoxygenase gene.
Manigrasso MB, O'Connor JP. Manigrasso MB, et al. Acta Orthop. 2010 Dec;81(6):748-55. doi: 10.3109/17453674.2010.533931. Epub 2010 Nov 11. Acta Orthop. 2010. PMID: 21067431 Free PMC article. - EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair.
Zhang M, Ho HC, Sheu TJ, Breyer MD, Flick LM, Jonason JH, Awad HA, Schwarz EM, O'Keefe RJ. Zhang M, et al. J Bone Miner Res. 2011 Apr;26(4):792-802. doi: 10.1002/jbmr.272. J Bone Miner Res. 2011. PMID: 20939055 Free PMC article. - Prostaglandin E(2) receptors in bone formation.
Li M, Thompson DD, Paralkar VM. Li M, et al. Int Orthop. 2007 Dec;31(6):767-72. doi: 10.1007/s00264-007-0406-x. Epub 2007 Jun 26. Int Orthop. 2007. PMID: 17593365 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources